AB Corporate Bond ETF (EYEG) To Go Ex-Dividend on May 1st

AB Corporate Bond ETF (NASDAQ:EYEGGet Free Report) declared a monthly dividend on Thursday, April 30th, NASDAQ Dividends reports. Shareholders of record on Friday, May 1st will be given a dividend of 0.1404 per share by the specialty pharmaceutical company on Wednesday, May 6th. This represents a c) dividend on an annualized basis and a dividend yield of 4.8%. The ex-dividend date of this dividend is Friday, May 1st.

AB Corporate Bond ETF Stock Performance

Shares of EYEG stock opened at $35.25 on Friday. AB Corporate Bond ETF has a 52-week low of $34.59 and a 52-week high of $36.63. The company has a quick ratio of 3.07, a current ratio of 3.07 and a debt-to-equity ratio of 0.01. The stock has a market cap of $28.20 million, a PE ratio of -20.98 and a beta of 0.23. The business has a 50-day simple moving average of $35.47 and a 200-day simple moving average of $35.81.

AB Corporate Bond ETF Company Profile

(Get Free Report)

EyeGate Pharmaceuticals, Inc is a clinical stage specialty pharmaceutical company, which engages in the development and commercialization of products for treating diseases and disorders of the eye. Its pipeline includes MoxiGel and Ocular Bandage Gel. The company was founded in 1998 and is headquartered in Waltham, MA.

Further Reading

Dividend History for AB Corporate Bond ETF (NASDAQ:EYEG)

Receive News & Ratings for AB Corporate Bond ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AB Corporate Bond ETF and related companies with MarketBeat.com's FREE daily email newsletter.